Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Inverness Building Consumer Product Sales, Has High Hopes For Clearblue

This article was originally published in The Tan Sheet

Executive Summary

Consumer products contributed roughly three-quarters of Inverness Medical Innovations' $65.7 mil. second quarter net revenues, the firm reported in a July 31 earnings call

You may also be interested in...



Inverness

June launch of Clearblue digital pregancy test to be followed by digital ovulation test next year, CEO Ron Zwanziger says at UBS Global Life Sciences Conference Sept. 23 (1"The Tan Sheet" Aug. 4, 2003, p. 9). Fifteen-second ad spots for Clearblue digital pregnancy test began airing on network TV Sept. 15, are slated to break on cable TV in October, he states. Tagline "if only everything in life were this clear," created by Christian, Baum and Bond (New York), targets women ages 25-36. "It is too early to say how sales [of the product] are doing, but we have seen encouraging early results," Zwanziger notes, predicting Inverness Medical Innovations revenues will reach $275 mil. in FY 2003...

Inverness

June launch of Clearblue digital pregancy test to be followed by digital ovulation test next year, CEO Ron Zwanziger says at UBS Global Life Sciences Conference Sept. 23 (1"The Tan Sheet" Aug. 4, 2003, p. 9). Fifteen-second ad spots for Clearblue digital pregnancy test began airing on network TV Sept. 15, are slated to break on cable TV in October, he states. Tagline "if only everything in life were this clear," created by Christian, Baum and Bond (New York), targets women ages 25-36. "It is too early to say how sales [of the product] are doing, but we have seen encouraging early results," Zwanziger notes, predicting Inverness Medical Innovations revenues will reach $275 mil. in FY 2003...

Inverness

June launch of Clearblue digital pregancy test to be followed by digital ovulation test next year, CEO Ron Zwanziger says at UBS Global Life Sciences Conference Sept. 23 (1"The Tan Sheet" Aug. 4, 2003, p. 9). Fifteen-second ad spots for Clearblue digital pregnancy test began airing on network TV Sept. 15, are slated to break on cable TV in October, he states. Tagline "if only everything in life were this clear," created by Christian, Baum and Bond (New York), targets women ages 25-36. "It is too early to say how sales [of the product] are doing, but we have seen encouraging early results," Zwanziger notes, predicting Inverness Medical Innovations revenues will reach $275 mil. in FY 2003...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS095769

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel